Vitamins for chronic disease prevention in adults: Scientific review

JAMA

Volumn 287, Issue 23, 2002, Pages 3116-3126

  Fairfield, Kathleen M ^a,b   Fletcher, Robert H ^c,d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD PILGRIM HEALTH CARE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM; CAROTENOID; CYANOCOBALAMIN; FOLIC ACID; LYCOPENE; NICOTINIC ACID; PYRIDOXINE; RETINOL; RIBOFLAVIN; THIAMINE; VITAMIN; VITAMIN D; VITAMIN K GROUP;

ADULT; AGING; ALCOHOLISM; ARTICLE; CANCER; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPED COUNTRY; FEMALE; FRACTURE; HUMAN; ISCHEMIC HEART DISEASE; MALABSORPTION; MALE; NEURAL TUBE DEFECT; OSTEOPOROSIS; PREGNANCY; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; VEGETARIAN; VITAMIN DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION;

EID: 0037134872     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.23.3116     Document Type: Article

References (152)

1. Vitamin and mineral supplement use in the United States: Results from the third National Health and Nutrition Examination Survey
2. Serum folate and risk of fatal coronary heart disease
3. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women
4. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
5. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
6. Endpoints for homocysteine-lowering trials
7. Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men
8. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study
9. Nutritional status of folate and colon cancer risk: Evidence from NHANES I epidemiologic follow-up study
10. A prospective study of folate intake and the risk of breast cancer
11. Dietary folate consumption and breast cancer risk
12. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women
13. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects
14. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
15. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
16. Vitamin E consumption and the risk of coronary disease in women
17. Vitamin E consumption and the risk of coronary heart disease in men
18. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction
19. Effect of vitamin E and beta carotene on the incidence of angina pectoris: A randomized, double-blind, controlled trial
20. Vitamin E supplementation and cardiovascular events in high-risk patients
21. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice
22. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
23. Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis
24. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States
25. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers: The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group
26. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
27. Prospective association between lipid soluble antioxidants and coronary heart disease in men: The Multiple Risk Factor Intervention Trial
28. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
29. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
30. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
31. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation
32. Prospective study of smoking, antioxidant intake, and lung cancer in middle-aged women (USA)
33. Role of various carotenoids in lung cancer prevention
34. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts
35. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: The Women's Health Study
36. Intake of carotenoids and retinol in relation to risk of prostate cancer
37. Cohort study of diet, lifestyle, and prostate cancer in Adventist men
38. A cohort study of diet and prostate cancer risk
39. The effect of nutritional and clinical factors upon serum prostate specific antigen and prostate cancer risk' in a population of elderly California men
40. Serologic precursors of cancer: Retinol, carotenoids, and tocopherol and risk of prostate cancer
41. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii
42. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from the multiple outcomes of raloxifene evaluation clinical trial
43. Hypovitaminosis D in medical inpatients
44. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications
45. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
46. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project
47. Homocysteine and atherothrombosis
48. The effect of folic acid fortification on plasma folate and total homocysteine concentrations
49. Thiamin, riboflavin, and vitamin B6 contents of selected foods as served
50. Current concepts in the diagnosis of cobalamin deficiency
51. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study
52. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): Population reference ranges and contribution of vitamin status to high serum concentrations
53. Randomized trial of folic acid supplementation and serum homocysteine levels
54. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
55. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia
56. Low circulating folate and vitamin B6 concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease
57. Folate and cancer prevention: A new medical application of folate beyond hyperhomocysteinemia and neural tube defects
58. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer
59. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer
60. Vitamin deficiencies and neural tube defects
61. Periconceptional use of multivitamins and the occurrence of neural tube defects
62. Dietary folate as a risk factor for neural-tube defects: Evidence from a case-control study in Western Australia
63. Periconceptional folic acid exposure and risk of occurrent neural tube defects
64. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects
65. Apparent prevention of neural tube defects by periconceptional vitamin supplementation
66. Quantifying the effect of folic acid
67. Gamma-tocopherol: A new player in prostate cancer prevention?
68. Vitamin E supplementation and in vivo immune response in healthy elderly subjects: A randomized controlled trial
69. Vitamin E content of foods
70. Inhibition of cell proliferation by alpha-tocopherol: Role of protein kinase C
71. Vitamin E: More than an antioxidant
72. Cost-effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial): Cambridge Heart Antioxidant Study
73. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial
74. Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer
75. Epidemiologic evidence for beta-carotene and cancer prevention
76. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: Effects of baseline characteristics and study compliance
77. Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States)
78. Alcohol consumption and risk of colorectal cancer in a cohort of Finnish men
79. Beta-carotene, vitamin A, and lung cancer chemoprevention: Results of an intermediate endpoint study
80. The independent association of smoking and drinking with serum beta-carotene levels among males in Miyagi, Japan
81. Relationship of alcohol use, physical activity and dietary habits with serum carotenoids, retinol and alpha-tocopherol among male Japanese smokers
82. Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
83. Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma
84. Tomatoes, tomato-based products, lycopene, and cancer: Review of the epidemiologic literature
85. Diet and breast cancer: Review of the epidemiologic literature
86. Intake of vitamins A, C, and E and postmenopausal breast cancer: The Iowa Women's Health Study
87. Vitamins C and E, retinol, beta-carotene and dietary fibre in relation to breast cancer risk: A prospective cohort study
88. Diet and breast cancer risk in a cohort of Finnish women
89. Dietary antioxidant vitamins, retinol, and breast cancer incidence in a cohort of Swedish women
90. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer
91. Relation of serum vitamins A and E and carotenoids to the risk of cancer
92. Plasma retinol, beta-carotene and vitamin E levels in relation to the future risk of breast cancer
93. Serum vitamin A and subsequent risk of cancer: Cancer incidence follow-up of the Finnish Mobile Clinic Health Examination Survey
94. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland
95. Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: Results from a prospective study in Columbia, Missouri (United States)
96. Serum carotenoids and breast cancer
97. Antioxidants and atherosclerotic heart disease
98. Carotenoids, vitamins C and E, and mortality in an elderly population
99. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture
100. Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: Associations with forearm bone mineral density
101. Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women
102. Vitamin D supplementation and fracture incidence in elderly persons: A randomized, placebo-controlled clinical trial
103. Prediction of bone density from vitamin D receptor alleles
104. Vitamin D receptor genotype and the risk of bone fractures in women
105. Polymorphism in the vitamin D receptor gene and bone mass in African-American and white mothers and children: A preliminary report
106. Vitamin C content of foods: Sample variability
107. Ascorbic acid overdosing: A risk factor for calcium oxalate nephrolithiasis
108. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men
109. Dietary antioxidants and carotid artery wall thickness: The ARIC Study
110. Antioxidant vitamin intake and coronary mortality in a longitudinal population study
111. Vitamin C deficiency and risk of myocardial infarction: Prospective population study of men from eastern Finland
112. The effect of fruit and vegetable intake on risk for coronary heart disease
113. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people
114. Vitamin C intake and mortality among a sample of the United States population
115. Leukocyte ascorbic acid and its relationship to coronary artery disease in man
116. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis
117. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty: Multivitamins and Probucol Study Group
118. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: A prospective population study
119. Vitamin C status and mortality in US adults
120. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: The Established Populations for Epidemiologic Studies of the Elderly
121. Design of Physicians' Health Study II: A randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials
122. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women: Rationale, design, and methods
123. Epidemiologic evidence for vitamin C and vitamin E in cancer prevention
124. Selected micronutrients and oral and pharyngeal cancer
125. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors
126. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients
127. Meta-analysis of studies on breast cancer risk and diet: The role of fruit and vegetable consumption and the intake of associated micronutrients
128. A prospective study of plasma ascorbic acid concentrations and breast cancer (United States)
129. Teratogenicity of high vitamin A intake
130. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture
131. Vitamin A intake and hip fractures among postmenopausal women
132. Vitamin A supplementation and child mortality: A meta-analysis
133. Nutrition and bladder cancer
134. Diet and bladder cancer: A meta-analysis of six dietary variables
135. Vitamin A and cancers of the breast, large bowel, and prostate: Epidemiologic evidence
136. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer
137. The spectrum of vitamin K deficiency
138. Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients
139. Vitamin K: A practical guide to the dietary management of patients on warfarin
140. Correction of excessive anticoagulation with low-dose oral vitamin K1
141. Treatment of warfarin-associated coagulopathy with oral vitamin K: A randomised controlled trial
142. Skeletal functions of vitamin K-dependent proteins: Not just for clotting anymore
143. Role of vitamin K in bone metabolism
144. Vitamin K nutrition and osteoporosis
145. Serum vitamin K level and bone mineral density in post-menopausal women
146. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis
147. Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture
148. Vitamin K intake and hip fractures in women: A prospective study
149. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women
150. Annual injection of vitamin D and fractures of aged bones